Company intelligence / Profile preview
Belenos Biosciences
New York, New York, United Statesbelenosbio.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
The company is operating in stealth mode and has recently licensed two bispecific antibodies (CM512 and CM536) from Keymed Biosciences for development and commercialization globally, excluding the Greater China region[5].
- Modalities
- Bispecific antibodies
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
Keymed Biosciences (China)
Beyond the preview
Go deeper on Belenos Biosciences.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Belenos Biosciences.